Christopher McNulty
Financieel Directeur/CFO bij Ring Therapeutics, Inc.
Vermogen: 739 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Christopher McNulty
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
| Public Company | Biotechnology | 10 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
8
| Subsidiary | Medical Specialties | 8 |
| Public Company | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher McNulty via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member Chief Executive Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Chairman Founder Chief Tech/Sci/R&D Officer | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Doctorate Degree | |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman Chief Executive Officer | |
| IMMUNOGEN, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| Sanofi Corp. | Corporate Officer/Principal Corporate Officer/Principal | ||
| Tuck School of Business at Dartmouth | College/University | Corporate Officer/Principal Masters Business Admin | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Founder | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder | |
| University of Colorado Boulder | College/University | Doctorate Degree Doctorate Degree | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Founder | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Licensing Executives Society | Corporate Officer/Principal Corporate Officer/Principal | ||
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| SPERO THERAPEUTICS, INC. | Biotechnology | General Counsel Human Resources Officer | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Genzyme Genetics, Inc.
 Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Medical/Nursing Services | President Corporate Officer/Principal | |
| BIO-REFERENCE LABORATORIES INC | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Administrative Officer Director of Finance/CFO | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Founder Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Canada | 4 |
| Israël | 4 |
| Ierland | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Health Services | 4 |
| Finance | 3 |
Operationeel
| Director/Board Member | 294 |
| Corporate Officer/Principal | 138 |
| Independent Dir/Board Member | 89 |
| Founder | 56 |
| Chairman | 56 |
Sterkste connecties
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Tomer Kariv | 46 |
| Steven Rubin | 37 |
| Francois Nader | 28 |
| David Epstein | 28 |
| C. Merrifield | 24 |
| Scott Requadt | 23 |
| Rahul Singhvi | 22 |
| Daniel Marshak | 21 |
| Tamara Joseph | 19 |
| Jeffrey Hatfield | 18 |
| B. Parshall | 17 |
| Jonathan Lieber | 16 |
| Gregory Perry | 16 |
| Richard Toselli | 15 |
- Beurs
- Insiders
- Christopher McNulty
- Bedrijfsconnecties
